SOW
FENC icon

State of Wyoming’s Fennec Pharmaceuticals FENC Stock Holding History

State of Wyoming’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-233
Closed -$1.43K – 2021
2026
Q1 		$1.43K Sell
233
-76
-25% -$587 ﹤0.01% 1769
2025
Q4 		$2.38K Buy
309
+7
+2% +$57 ﹤0.01% 1766
2025
Q3 		$2.83K Sell
302
-186
-38% -$1.61K ﹤0.01% 1792
2025
Q2 		$4.05K Sell
488
-826
-63% -$5.65K ﹤0.01% 1795
2025
Q1 		$8K Buy
1,314
+175
+15% +$1.12K ﹤0.01% 1580
2024
Q4 		$7.2K Sell
1,139
-482
-30% -$2.47K ﹤0.01% 1542
2024
Q3 		$8.11K Sell
1,621
-122
-7% -$706 ﹤0.01% 1619
2024
Q2 		$10.7K Sell
1,743
-333
-16% -$2.77K ﹤0.01% 1574
2024
Q1 		$23.1K Sell
2,076
-404
-16% -$4.06K ﹤0.01% 1531
2023
Q4 		$27.8K Buy
2,480
+285
+13% +$2.36K 0.01% 1523
2023
Q3 		$16.5K Buy
2,195
+532
+32% +$4.33K ﹤0.01% 1515
2023
Q2 		$14.7K Buy
1,663
+859
+107% +$7.14K ﹤0.01% 1452
2023
Q1 		$6.69K Buy
+804
New +$7.46K ﹤0.01% 1511

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State of Wyoming's FENC Position: Q2 2026 in Review

State of Wyoming sold out of Fennec Pharmaceuticals (FENC) in Q2 2026, closing a stake of 233 shares — an estimated $1.43K sold.

State of Wyoming first reported a position in FENC in Q1 2023 and held it in 13 quarters. The position peaked at $27.8K in Q4 2023. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • State of Wyoming reported no remaining Fennec Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • State of Wyoming sold 233 Fennec Pharmaceuticals shares in Q2 2026, an estimated $1.43K.
  • State of Wyoming first reported a position in Fennec Pharmaceuticals in Q1 2023 and held it in 13 quarters.
  • State of Wyoming's Fennec Pharmaceuticals position peaked at $27.8K in Q4 2023.
  • 104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.